Related Experiment Video
Updated: Jul 15, 2026

Synthesis and Assay of Vibrio Quorum Sensing Inhibitors
Published on: May 31, 2024
Diarylquinolines target subunit c of mycobacterial ATP synthase
Anil Koul1, Najoua Dendouga, Karen Vergauwen
1Department of Antimicrobial Research, Tibotec BVBA, Johnson & Johnson, Turnhoutseweg 30, B-2340 Beerse, Belgium. akoul@prdbe.jnj.com
Abstract:
The diarylquinoline R207910 (TMC207) is a promising candidate in clinical development for the treatment of tuberculosis. Though R207910-resistant mycobacteria bear mutations in ATP synthase, the compound's precise target is not known. Here we establish by genetic, biochemical and binding assays that the oligomeric subunit c (AtpE) of ATP synthase is the target of R207910. Thus targeting energy metabolism is a new, promising approach for antibacterial drug discovery.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
ATP Synthase: Mechanism
Electron Transport Chain: Complex III and IV
Inhibitors of Bacterial Protein Synthesis
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
